Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Molecular Cancer Therapeutics|2021Cited by 6
Supplementary Figure Legends from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, Wendi Custer Lawrence et al.|Unknown|2023Cited by 0
Supplementary Figure 3 from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Novel Humanized Mesothelin-Expressing Genetically Engineered Mouse Models Underscore Challenges in Delivery of Complex Therapeutics to Pancreatic CancersBrendan Hagerty, Christine Alewine, T. Norene O’Sullivan et al.|Unknown|2023Cited by 0